APOE and dementia: Taken together, our findings suggest that the combined elevated neurodegenerative burdens imposed by APOE4 and neurodegenerative biomarkers were associated with an accelerated rate of cognitive decline in a biracial population of community-dwelling older adults without dementia compared with associations of either APOE4 or neurodegenerative biomarker alone.